Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nabelin Fuji Science Ties Up with 2 Medical Devices Wholesalers
April 15, 2002
- REGULATORY NEWS IN BRIEF
April 15, 2002
- Oticon: New Hearing Aid Adapto
April 15, 2002
- BULLETIN
April 15, 2002
- Medical Institutions Can Advertise from April 1
April 15, 2002
- Let the Change Be Your Friend: Mr Ogawa of Nippon Roche
April 15, 2002
- Yamanouchi to Nearly Achieve 6% Market Share: President Takenaka
April 8, 2002
- FY2002 Budget Approved by Diet
April 8, 2002
- Takeda Subscribes to Gene Logic's Gene Expression Database
April 8, 2002
- REGULATORY NEWS IN BRIEF
April 8, 2002
- Sankyo Transfers Development of Glaucoma Drug to Santen
April 8, 2002
- Elimination of Prescription Period Limitation Should Help Bungyo : Expert
April 8, 2002
- Nippon Shinyaku to Market HIGA Mice via Japan SLC
April 8, 2002
- Final Draft GL for Acute Pancreatitis Presented by JSAEM
April 8, 2002
- Otsuka, Otsuka Pharm Factory, Snow Brand Milk Create JV for Clinical Nutrition
April 8, 2002
- Korosho to Construct Critical Path-Sharing System
April 8, 2002
- Major Maker's New Invoice Prices Are More Acceptable than Before: Suzuken
April 8, 2002
- Doctors' Participation in Clinical Trial Training Disappointing
April 8, 2002
- BUSINESS NEWS IN BRIEF
April 8, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 8, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…